Per­son­al­ized can­cer vac­cines might make no­to­ri­ous­ly dead­ly brain can­cers more sus­cep­ti­ble to im­munother­a­py and pos­si­bly pro­long sur­vival for some pa­tients, ac­cord­ing to …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.